International Stem Cell Corp (ISCO) stock news · rev $5.0M
International Stem Cell Corp (ISCO) is a biotechnology company listed on US.
This ISCO news page leads with what International Stem Cell Corp filed — not a scraped headline mill.
No cached 8-K sentence for ISCO yet. We will not pad this page with generic market recap.
Latest reported ISCO revenue for 2026-06-30 was $5.0M. Net income was -$291.0K. ISCO currently screens at market cap $880.5K.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ISCO stock page; for the tape open the quote page.
Not investment advice.